An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease.
Journal
Nature aging
ISSN: 2662-8465
Titre abrégé: Nat Aging
Pays: United States
ID NLM: 101773306
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
16
06
2021
accepted:
23
05
2022
medline:
1
5
2023
pubmed:
29
4
2023
entrez:
28
4
2023
Statut:
ppublish
Résumé
Changes in the levels of circulating proteins are associated with Alzheimer's disease (AD), whereas their pathogenic roles in AD are unclear. Here, we identified soluble ST2 (sST2), a decoy receptor of interleukin-33-ST2 signaling, as a new disease-causing factor in AD. Increased circulating sST2 level is associated with more severe pathological changes in female individuals with AD. Genome-wide association analysis and CRISPR-Cas9 genome editing identified rs1921622 , a genetic variant in an enhancer element of IL1RL1, which downregulates gene and protein levels of sST2. Mendelian randomization analysis using genetic variants, including rs1921622 , demonstrated that decreased sST2 levels lower AD risk and related endophenotypes in females carrying the Apolipoprotein E (APOE)-ε4 genotype; the association is stronger in Chinese than in European-descent populations. Human and mouse transcriptome and immunohistochemical studies showed that rs1921622 /sST2 regulates amyloid-beta (Aβ) pathology through the modulation of microglial activation and Aβ clearance. These findings demonstrate how sST2 level is modulated by a genetic variation and plays a disease-causing role in females with AD.
Identifiants
pubmed: 37117777
doi: 10.1038/s43587-022-00241-9
pii: 10.1038/s43587-022-00241-9
pmc: PMC10154240
doi:
Substances chimiques
Interleukin-1 Receptor-Like 1 Protein
0
Apolipoprotein E4
0
Amyloid beta-Peptides
0
IL1RL1 protein, human
0
Il1rl1 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
616-634Subventions
Organisme : Medical Research Council
ID : G0701075
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0901254
Pays : United Kingdom
Investigateurs
Michael W Weiner
(MW)
Paul Aisen
(P)
Ronald Petersen
(R)
Clifford R Jack
(CR)
William Jagust
(W)
John Q Trojanowski
(JQ)
Arthur W Toga
(AW)
Laurel Beckett
(L)
Robert C Green
(RC)
Andrew J Saykin
(AJ)
John Morris
(J)
Leslie M Shaw
(LM)
Zaven Khachaturian
(Z)
Greg Sorensen
(G)
Lew Kuller
(L)
Marcus Raichle
(M)
Steven Paul
(S)
Peter Davies
(P)
Howard Fillit
(H)
Franz Hefti
(F)
David Holtzman
(D)
Marek M Mesulam
(MM)
William Potter
(W)
Peter Snyder
(P)
Adam Schwartz
(A)
Tom Montine
(T)
Ronald G Thomas
(RG)
Michael Donohue
(M)
Sarah Walter
(S)
Devon Gessert
(D)
Tamie Sather
(T)
Gus Jiminez
(G)
Danielle Harvey
(D)
Matthew Bernstein
(M)
Paul Thompson
(P)
Norbert Schuff
(N)
Bret Borowski
(B)
Jeff Gunter
(J)
Matt Senjem
(M)
Prashanthi Vemuri
(P)
David Jones
(D)
Kejal Kantarci
(K)
Chad Ward
(C)
Robert A Koeppe
(RA)
Norm Foster
(N)
Eric M Reiman
(EM)
Kewei Chen
(K)
Chet Mathis
(C)
Susan Landau
(S)
Nigel J Cairns
(NJ)
Erin Householder
(E)
Lisa Taylor-Reinwald
(L)
Virginia Lee
(V)
Magdalena Korecka
(M)
Michal Figurski
(M)
Karen Crawford
(K)
Scott Neu
(S)
Tatiana M Foroud
(TM)
Steven G Potkin
(SG)
Li Shen
(L)
Kelley Faber
(K)
Sungeun Kim
(S)
Kwangsik Nho
(K)
Leon Thal
(L)
Neil Buckholtz
(N)
Marylyn Albert
(M)
Richard Frank
(R)
John Hsiao
(J)
Jeffrey Kaye
(J)
Joseph Quinn
(J)
Betty Lind
(B)
Raina Carter
(R)
Sara Dolen
(S)
Lon S Schneider
(LS)
Sonia Pawluczyk
(S)
Mauricio Beccera
(M)
Liberty Teodoro
(L)
Bryan M Spann
(BM)
James Brewer
(J)
Helen Vanderswag
(H)
Adam Fleisher
(A)
Judith L Heidebrink
(JL)
Joanne L Lord
(JL)
Sara S Mason
(SS)
Colleen S Albers
(CS)
David Knopman
(D)
Kris Johnson
(K)
Rachelle S Doody
(RS)
Javier Villanueva-Meyer
(J)
Munir Chowdhury
(M)
Susan Rountree
(S)
Mimi Dang
(M)
Yaakov Stern
(Y)
Lawrence S Honig
(LS)
Karen L Bell
(KL)
Beau Ances
(B)
Maria Carroll
(M)
Sue Leon
(S)
Mark A Mintun
(MA)
Stacy Schneider
(S)
Angela Oliver
(A)
Daniel Marson
(D)
Randall Griffith
(R)
David Clark
(D)
David Geldmacher
(D)
John Brockington
(J)
Erik Roberson
(E)
Hillel Grossman
(H)
Effie Mitsis
(E)
Leyla de Toledo-Morrell
(L)
Raj C Shah
(RC)
Ranjan Duara
(R)
Daniel Varon
(D)
Maria T Greig
(MT)
Peggy Roberts
(P)
Chiadi Onyike
(C)
Daniel D'Agostino
(D)
Stephanie Kielb
(S)
James E Galvin
(JE)
Brittany Cerbone
(B)
Christina A Michel
(CA)
Henry Rusinek
(H)
Mony J de Leon
(MJ)
Lidia Glodzik
(L)
Susan De Santi
(S)
P Murali Doraiswamy
(PM)
Jeffrey R Petrella
(JR)
Terence Z Wong
(TZ)
Steven E Arnold
(SE)
Jason H Karlawish
(JH)
David Wolk
(D)
Charles D Smith
(CD)
Greg Jicha
(G)
Peter Hardy
(P)
Partha Sinha
(P)
Elizabeth Oates
(E)
Gary Conrad
(G)
Oscar L Lopez
(OL)
MaryAnn Oakley
(M)
Donna M Simpson
(DM)
Anton P Porsteinsson
(AP)
Bonnie S Goldstein
(BS)
Kim Martin
(K)
Kelly M Makino
(KM)
M Saleem Ismail
(MS)
Connie Brand
(C)
Ruth A Mulnard
(RA)
Gaby Thai
(G)
Catherine McAdams-Ortiz
(C)
Kyle Womack
(K)
Dana Mathews
(D)
Mary Quiceno
(M)
Ramon Diaz-Arrastia
(R)
Richard King
(R)
Myron Weiner
(M)
Kristen Martin-Cook
(K)
Michael DeVous
(M)
Allan I Levey
(AI)
James J Lah
(JJ)
Janet S Cellar
(JS)
Jeffrey M Burns
(JM)
Heather S Anderson
(HS)
Russell H Swerdlow
(RH)
Liana Apostolova
(L)
Kathleen Tingus
(K)
Ellen Woo
(E)
Daniel H S Silverman
(DHS)
Po H Lu
(PH)
George Bartzokis
(G)
Neill R Graff-Radford
(NR)
Francine Parfitt
(F)
Tracy Kendall
(T)
Heather Johnson
(H)
Martin R Farlow
(MR)
Ann Marie Hake
(AM)
Brandy R Matthews
(BR)
Scott Herring
(S)
Cynthia Hunt
(C)
Christopher H van Dyck
(CH)
Richard E Carson
(RE)
Martha G MacAvoy
(MG)
Howard Chertkow
(H)
Howard Bergman
(H)
Chris Hosein
(C)
Ging-Yuek Robin Hsiung
(GR)
Howard Feldman
(H)
Benita Mudge
(B)
Michele Assaly
(M)
Charles Bernick
(C)
Donna Munic
(D)
Andrew Kertesz
(A)
John Rogers
(J)
Dick Trost
(D)
Diana Kerwin
(D)
Kristine Lipowski
(K)
Chuang-Kuo Wu
(CK)
Nancy Johnson
(N)
Carl Sadowsky
(C)
Walter Martinez
(W)
Teresa Villena
(T)
Raymond Scott Turner
(RS)
Kathleen Johnson
(K)
Brigid Reynolds
(B)
Reisa A Sperling
(RA)
Keith A Johnson
(KA)
Gad Marshall
(G)
Meghan Frey
(M)
Barton Lane
(B)
Allyson Rosen
(A)
Jared Tinklenberg
(J)
Marwan N Sabbagh
(MN)
Christine M Belden
(CM)
Sandra A Jacobson
(SA)
Sherye A Sirrel
(SA)
Neil Kowall
(N)
Ronald Killiany
(R)
Andrew E Budson
(AE)
Alexander Norbash
(A)
Patricia Lynn Johnson
(PL)
Joanne Allard
(J)
Alan Lerner
(A)
Paula Ogrocki
(P)
Leon Hudson
(L)
Evan Fletcher
(E)
Owen Carmichael
(O)
John Olichney
(J)
Charles DeCarli
(C)
Smita Kittur
(S)
Michael Borrie
(M)
T-Y Lee
(TY)
Rob Bartha
(R)
Sterling Johnson
(S)
Sanjay Asthana
(S)
Cynthia M Carlsson
(CM)
Adrian Preda
(A)
Dana Nguyen
(D)
Pierre Tariot
(P)
Stephanie Reeder
(S)
Vernice Bates
(V)
Horacio Capote
(H)
Michelle Rainka
(M)
Douglas W Scharre
(DW)
Maria Kataki
(M)
Anahita Adeli
(A)
Earl A Zimmerman
(EA)
Dzintra Celmins
(D)
Alice D Brown
(AD)
Godfrey D Pearlson
(GD)
Karen Blank
(K)
Karen Anderson
(K)
Robert B Santulli
(RB)
Tamar J Kitzmiller
(TJ)
Eben S Schwartz
(ES)
Kaycee M Sink
(KM)
Jeff D Williamson
(JD)
Pradeep Garg
(P)
Franklin Watkins
(F)
Brian R Ott
(BR)
Henry Querfurth
(H)
Geoffrey Tremont
(G)
Stephen Salloway
(S)
Paul Malloy
(P)
Stephen Correia
(S)
Howard J Rosen
(HJ)
Bruce L Miller
(BL)
Jacobo Mintzer
(J)
Kenneth Spicer
(K)
David Bachman
(D)
Stephen Pasternak
(S)
Irina Rachinsky
(I)
Dick Drost
(D)
Nunzio Pomara
(N)
Raymundo Hernando
(R)
Antero Sarrael
(A)
Susan K Schultz
(SK)
Laura L Boles Ponto
(LLB)
Hyungsub Shim
(H)
Karen Elizabeth Smith
(KE)
Norman Relkin
(N)
Gloria Chaing
(G)
Lisa Raudin
(L)
Amanda Smith
(A)
Kristin Fargher
(K)
Balebail Ashok Raj
(BA)
Thomas Neylan
(T)
Jordan Grafman
(J)
Melissa Davis
(M)
Rosemary Morrison
(R)
Jacqueline Hayes
(J)
Shannon Finley
(S)
Karl Friedl
(K)
Debra Fleischman
(D)
Konstantinos Arfanakis
(K)
Olga James
(O)
Dino Massoglia
(D)
J Jay Fruehling
(JJ)
Sandra Harding
(S)
Elaine R Peskind
(ER)
Eric C Petrie
(EC)
Gail Li
(G)
Jerome A Yesavage
(JA)
Joy L Taylor
(JL)
Ansgar J Furst
(AJ)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. The Author(s).
Références
Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement. 15, 321–387 (2019).
Jack, C. R. Jr et al. NIA‐AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14, 535–562 (2018).
pubmed: 29653606
pmcid: 5958625
doi: 10.1016/j.jalz.2018.02.018
Lambert, J.-C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).
pubmed: 24162737
pmcid: 3896259
doi: 10.1038/ng.2802
Frigerio, C. S. et al. The major risk factors for Alzheimer’s disease: age, sex and genes modulate the microglia response to Aβ plaques. Cell Rep. 27, 1293–1306 (2019).
pmcid: 7340153
doi: 10.1016/j.celrep.2019.03.099
Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 binds to apolipoproteins, including APOE and CLU/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328–340 (2016).
pubmed: 27477018
doi: 10.1016/j.neuron.2016.06.015
Rebeck, G. W., Reiter, J. S., Strickland, D. K. & Hyman, B. T. Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron 11, 575–580 (1993).
pubmed: 8398148
doi: 10.1016/0896-6273(93)90070-8
Kok, E. et al. Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age. Ann. Neurol. 65, 650–657 (2009).
pubmed: 19557866
doi: 10.1002/ana.21696
Castellano, J. M. et al. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci. Transl. Med. 3, 89ra57 (2011).
pubmed: 21715678
pmcid: 3192364
doi: 10.1126/scitranslmed.3002156
Stephen, T. L. et al. APOE genotype and sex affect microglial interactions with plaques in Alzheimer’s disease mice. Acta Neuropathol. Commun. 7, 82 (2019).
Hickman, S. E., Allison, E. K. & El Khoury, J. Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer’s disease mice. J. Neurosci. 28, 8354–8360 (2008).
pubmed: 18701698
pmcid: 2597474
doi: 10.1523/JNEUROSCI.0616-08.2008
Guillot-Sestier, M.-V. et al. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85, 534–548 (2015).
pubmed: 25619654
pmcid: 4352138
doi: 10.1016/j.neuron.2014.12.068
Suárez-Calvet, M. et al. Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury. Sci. Transl. Med. 8, 369ra178 (2016).
pubmed: 27974666
pmcid: 5385711
doi: 10.1126/scitranslmed.aag1767
Ewers, M. et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease. Sci. Transl. Med. 11, eaav6221 (2019).
Wood, H. Soluble TREM2 in CSF sheds light on microglial activation in AD. Nat. Rev. Neurol. 13, 65–65 (2017).
pubmed: 28084325
doi: 10.1038/nrneurol.2016.203
Zhong, L. et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J. Exp. Med. 214, 597–607 (2017).
pubmed: 28209725
pmcid: 5339672
doi: 10.1084/jem.20160844
Zhong, L. et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model. Nat. Commun. 10, 1–16 (2019).
Janelidze, S. et al. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease. Neurology 91, e867–e877 (2018).
pubmed: 30054439
pmcid: 6133624
doi: 10.1212/WNL.0000000000006082
Huang, C.-W. et al. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer’s dementia. Thromb. Haemost. 114, 1230–1240 (2015).
pubmed: 26289958
doi: 10.1160/TH14-11-0938
Yousef, H. et al. Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1. Nat. Med. 25, 988–1000 (2019).
pubmed: 31086348
pmcid: 6642642
doi: 10.1038/s41591-019-0440-4
Chakrabarty, P. et al. TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease. J. Exp. Med. 215, 2247–2264 (2018).
pubmed: 30158114
pmcid: 6122970
doi: 10.1084/jem.20180484
Liu, Y. -L. et al. Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model. Mol. Neurodegener. 12, 30 (2017).
Griesenauer, B. & Paczesny, S. The ST2/IL-33 axis in immune cells during inflammatory diseases. Front. Immunol. 8, 475 (2017).
pubmed: 28484466
pmcid: 5402045
doi: 10.3389/fimmu.2017.00475
Yasuoka, S. et al. Production and functions of IL-33 in the central nervous system. Brain Res. 1385, 8–17 (2011).
pubmed: 21349253
doi: 10.1016/j.brainres.2011.02.045
Fu, A. K. et al. IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline. Proc. Natl Acad. Sci. USA 113, E2705–E2713 (2016).
pubmed: 27091974
pmcid: 4868478
doi: 10.1073/pnas.1604032113
Lau, S.-F. et al. IL-33-PU.1 transcriptome reprogramming drives functional state transition and clearance activity of microglia in Alzheimer’s disease. Cell Rep. 31, 107530 (2020).
pubmed: 32320664
doi: 10.1016/j.celrep.2020.107530
Trajkovic, V., Sweet, M. J. & Xu, D. T1/ST2—an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev. 15, 87–95 (2004).
pubmed: 15110792
doi: 10.1016/j.cytogfr.2004.02.004
Kakkar, R. & Lee, R. T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 7, 827–840 (2008).
pubmed: 18827826
pmcid: 4277436
doi: 10.1038/nrd2660
Homsak, E. & Gruson, D. Soluble ST2: a complex and diverse role in several diseases. Clin. Chim. Acta 507, 75–87 (2020).
Oshikawa, K. et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 164, 277–281 (2001).
pubmed: 11463601
doi: 10.1164/ajrccm.164.2.2008120
Bergis, D., Kassis, V. & Radeke, H. H. High plasma sST2 levels in gastric cancer and their association with metastatic disease. Cancer Biomark. 16, 117–125 (2016).
pubmed: 26835712
doi: 10.3233/CBM-150547
Villacorta, H. & Maisel, A. S. Soluble ST2 testing: a promising biomarker in the management of heart failure. Arq. Bras. Cardiol. 106, 145–152 (2016).
pubmed: 26761075
pmcid: 4765013
Saresella, M. et al. IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment. J. Neuroinflammation 17, 174 (2020).
pubmed: 32505187
pmcid: 7276088
doi: 10.1186/s12974-020-01806-4
Karikari, T. K. et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 19, 422–433 (2020).
pubmed: 32333900
doi: 10.1016/S1474-4422(20)30071-5
Preische, O. et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nat. Med. 25, 277–283 (2019).
pubmed: 30664784
pmcid: 6367005
doi: 10.1038/s41591-018-0304-3
Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease. Nature 577, 399–404 (2020).
pubmed: 31915375
pmcid: 7445078
doi: 10.1038/s41586-019-1895-7
Sasayama, D. et al. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J. Psychiatric Res. 47, 401–406 (2013).
doi: 10.1016/j.jpsychires.2012.12.001
Lehallier, B. et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat. Med. 25, 1843–1850 (2019).
pubmed: 31806903
pmcid: 7062043
doi: 10.1038/s41591-019-0673-2
Ho, J. E. et al. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. J. Clin. Invest. 123, 4208–4218 (2013).
pubmed: 23999434
pmcid: 3784527
doi: 10.1172/JCI67119
Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73–79 (2018).
pubmed: 29875488
pmcid: 6697541
doi: 10.1038/s41586-018-0175-2
Grotenboer, N. S., Ketelaar, M. E., Koppelman, G. H. & Nawijn, M. C. Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J. Allergy Clin. Immunol.131, 856–865 (2013).
pubmed: 23380221
doi: 10.1016/j.jaci.2012.11.028
Zhou, X. et al. Non-coding variability at the APOE locus contributes to the Alzheimer’s risk. Nat. Commun. 10, 3310 (2019).
pubmed: 31346172
pmcid: 6658518
doi: 10.1038/s41467-019-10945-z
Lonsdale, J. et al. The Genotype-Tissue Expression project. Nat. Genet. 45, 580–585 (2013).
doi: 10.1038/ng.2653
Consortium, G. The Genotype-Tissue Expression pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).
doi: 10.1126/science.1262110
Lau, S.-F., Cao, H., Fu, A. K. & Ip, N. Y. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer’s disease. Proc. Natl Acad. Sci. USA 117, 25800–25809 (2020).
pubmed: 32989152
pmcid: 7568283
doi: 10.1073/pnas.2008762117
Li, W., Notani, D. & Rosenfeld, M. G. Enhancers as non-coding RNA transcription units: recent insights and future perspectives. Nat. Rev. Genet. 17, 207–223 (2016).
doi: 10.1038/nrg.2016.4
Davies, N. M., Holmes, M. V. & Smith, G. D. Reading Mendelian randomisation studies: a guide, glossary and checklist for clinicians. BMJ 362, k601 (2018).
Zhou, X. et al. Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis. Proc. Natl Acad. Sci. USA 115, 1697–1706 (2018).
pubmed: 29432188
pmcid: 5828602
doi: 10.1073/pnas.1715554115
Lee, J. H., Cheng, R., Graff-Radford, N., Foroud, T. & Mayeux, R. Analyses of the National Institute on Aging late-onset alzheimer’s disease family study: implication of additional loci. Arch. Neurol. 65, 1518–1526 (2008).
pubmed: 19001172
pmcid: 2694670
doi: 10.1001/archneur.65.11.1518
Naj, A. C. et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat. Genet. 43, 436–441 (2011).
pubmed: 21460841
pmcid: 3090745
doi: 10.1038/ng.801
Jun, G. et al. Meta-analysis confirms CR1, CLU and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol. 67, 1473–1484 (2010).
pubmed: 20697030
pmcid: 3048805
doi: 10.1001/archneurol.2010.201
Han, B. & Eskin, E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am. J. Hum. Genet. 88, 586–598 (2011).
pubmed: 21565292
pmcid: 3146723
doi: 10.1016/j.ajhg.2011.04.014
Kathryn, A. E. et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1,112 individuals recruited for a longitudinal study of Alzheimer’s disease. Int. Psychogeriatr. 21, 672–687 (2009).
Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 570, 332–337 (2019).
pubmed: 31042697
pmcid: 6865822
doi: 10.1038/s41586-019-1195-2
Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease. Nat. Med. 26, 131–142 (2020).
pubmed: 31932797
pmcid: 6980793
doi: 10.1038/s41591-019-0695-9
Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290 (2017).
pubmed: 28602351
doi: 10.1016/j.cell.2017.05.018
Thrupp, N. et al. Single-nucleus RNA-seq is not suitable for detection of microglial activation genes in humans. Cell Rep. 32, 108189 (2020).
pubmed: 32997994
pmcid: 7527779
doi: 10.1016/j.celrep.2020.108189
Yuan, P. et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90, 724–739 (2016).
pubmed: 27196974
pmcid: 4898967
doi: 10.1016/j.neuron.2016.05.003
Wicher, G. et al. Interleukin-33 promotes recruitment of microglia/macrophages in response to traumatic brain injury. J. Neurotrauma 34, 3173–3182 (2017).
pubmed: 28490277
doi: 10.1089/neu.2016.4900
Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929–11947 (2014).
pubmed: 25186741
pmcid: 4152602
doi: 10.1523/JNEUROSCI.1860-14.2014
Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).
Wang, Y. et al. Astrocyte-secreted IL-33 mediates homeostatic synaptic plasticity in the adult hippocampus. Proc. Natl Acad. Sci. USA 118, e2020810118 (2021).
Nguyen, P. T. et al. Microglial remodeling of the extracellular matrix promotes synapse plasticity. Cell 182, 388–403 (2020).
pubmed: 32615087
pmcid: 7497728
doi: 10.1016/j.cell.2020.05.050
Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37–53 (2016).
pubmed: 26687838
doi: 10.1016/j.neuron.2015.11.013
Kalari, K. R. et al. BBBomics—human blood–brain barrier transcriptomics hub. Front. Neurosci.10, 71 (2016).
pubmed: 26973449
pmcid: 4771746
doi: 10.3389/fnins.2016.00071
Demyanets, S. et al. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J. Mol. Cellular Cardiol. 60, 16–26 (2013).
doi: 10.1016/j.yjmcc.2013.03.020
Joshi, A. D. et al. Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. BMC Immunol. 11, 52 (2010).
pubmed: 20958987
pmcid: 2967528
doi: 10.1186/1471-2172-11-52
Bandara, G., Beaven, M. A., Olivera, A., Gilfillan, A. M. & Metcalfe, D. D. Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33. Eur. J. Immunol. 45, 3034–3044 (2015).
pubmed: 26256265
pmcid: 4813659
doi: 10.1002/eji.201545501
Zhang, J. et al. ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease. Sci. Transl. Med. 7, 308ra160 (2015).
pubmed: 26446957
pmcid: 4699312
doi: 10.1126/scitranslmed.aab0166
Lipsky, B. P., Toy, D. Y., Swart, D. A., Smithgall, M. D. & Smith, D. Deletion of the ST2 proximal promoter disrupts fibroblast‐specific expression but does not reduce the amount of soluble ST2 in circulation. Eur. J. Immunol. 42, 1863–1869 (2012).
pubmed: 22585662
doi: 10.1002/eji.201142274
Kikuchi, M. et al. Altered behavior in mice overexpressing soluble ST2. Mol. Brain 13, 74 (2020).
Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat. Rev. Neurosci. 12, 723–738 (2011).
pubmed: 22048062
pmcid: 4036520
doi: 10.1038/nrn3114
Hilscher, M. B. et al. Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi and promote portal hypertension. Gastroenterology 157, 193–209 (2019).
pubmed: 30872106
doi: 10.1053/j.gastro.2019.03.013
Grammas, P. & Ovase, R. Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease. Neurobiol. Aging 22, 837–842 (2001).
pubmed: 11754990
doi: 10.1016/S0197-4580(01)00276-7
Grammas, P. & Ovase, R. Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer’s disease brain. Am. J. Pathol. 160, 1583–1587 (2002).
pubmed: 12000710
pmcid: 1850858
doi: 10.1016/S0002-9440(10)61105-4
Ferretti, M. T. et al. Sex differences in Alzheimer disease—the gateway to precision medicine. Nat. Rev. Neurol. 14, 457–469 (2018).
pubmed: 29985474
doi: 10.1038/s41582-018-0032-9
Laws, K. R., Irvine, K. & Gale, T. M. Sex differences in Alzheimer’s disease. Curr. Opin. Psych. 31, 133–139 (2018).
doi: 10.1097/YCO.0000000000000401
Laws, K. R., Irvine, K. & Gale, T. M. Sex differences in cognitive impairment in Alzheimer’s disease. World J. Psychiatry 6, 54–65 (2016).
pubmed: 27014598
pmcid: 4804268
doi: 10.5498/wjp.v6.i1.54
Guillot-Sestier, M. -V. et al. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer’s disease. Commun. Biol. 4, 711 (2021).
Russi, A. E., Ebel, M. E., Yang, Y. & Brown, M. A. Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility. Proc. Natl Acad. Sci. USA 115, E1520–E1529 (2018).
pubmed: 29378942
pmcid: 5816140
doi: 10.1073/pnas.1710401115
Fernandez, C. G., Hamby, M. E., McReynolds, M. L. & Ray, W. J. The role of APOE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer’s disease. Front. Aging Neurosci. 11, 14 (2019).
pubmed: 30804776
pmcid: 6378415
doi: 10.3389/fnagi.2019.00014
Fourgeaud, L. et al. TAM receptors regulate multiple features of microglial physiology. Nature 532, 240–244 (2016).
pubmed: 27049947
pmcid: 5358512
doi: 10.1038/nature17630
Kim, J., Basak, J. M. & Holtzman, D. M. The role of apolipoprotein E in Alzheimer’s disease. Neuron 63, 287–303 (2009).
pubmed: 19679070
pmcid: 3044446
doi: 10.1016/j.neuron.2009.06.026
Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model. Cell 160, 1061–1071 (2015).
pubmed: 25728668
pmcid: 4477963
doi: 10.1016/j.cell.2015.01.049
Mittal, K. et al. CD4 T cells induce a subset of MHCII-expressing microglia that attenuates Alzheimer pathology. iScience 16, 298–311 (2019).
pubmed: 31203186
pmcid: 6581663
doi: 10.1016/j.isci.2019.05.039
Miller, A. M. et al. IL-33 reduces the development of atherosclerosis. J. Exp. Med. 205, 339–346 (2008).
pubmed: 18268038
pmcid: 2271006
doi: 10.1084/jem.20071868
Baba, Y. et al. Involvement of PU.1 in mast cell/basophil-specific function of the human IL1RL1/ST2 promoter. Allergol. Int. 61, 461–467 (2012).
pubmed: 22824976
doi: 10.2332/allergolint.12-OA-0424
Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).
pubmed: 30820047
pmcid: 6463297
doi: 10.1038/s41588-019-0358-2
Jun, G. et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol. Psychiatry 21, 108–117 (2016).
pubmed: 25778476
doi: 10.1038/mp.2015.23
O’Meara, E. et al. Independent prognostic value of serum soluble ST2 measurements in patients with heart failure and a reduced ejection fraction in the PARADIGM-HF trial (prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure). Circ. Heart Fail. 11, e004446 (2018).
pubmed: 29748349
doi: 10.1161/CIRCHEARTFAILURE.117.004446
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn. (American Psychiatric Association, 2013).
Pangman, V. C., Sloan, J. & Guse, L. An examination of psychometric properties of the Mini-Mental State Examination and the standardized mini-mental state examination: implications for clinical practice. Appl. Nurs. Res. 13, 209–213 (2000).
pubmed: 11078787
doi: 10.1053/apnr.2000.9231
Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695–699 (2005).
pubmed: 15817019
doi: 10.1111/j.1532-5415.2005.53221.x
Jiang, Y. et al. Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer’s disease screening and staging. Alzheimers Dement. 18, 88–102 (2021).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
pubmed: 17701901
pmcid: 1950838
doi: 10.1086/519795
Hormozdiari, F., Kostem, E., Kang, E. Y., Pasaniuc, B. & Eskin, E. Identifying causal variants at loci with multiple signals of association. Genetics 198, 497–508 (2014).
pubmed: 25104515
pmcid: 4196608
doi: 10.1534/genetics.114.167908
Grömping, U. Relative importance for linear regression in R: the package relaimpo. J. Stat. Softw. 17, 1–27 (2006).
doi: 10.18637/jss.v017.i01
Patin, E. et al. Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors. Nat. Immunol. 19, 302–314 (2018).
pubmed: 29476184
doi: 10.1038/s41590-018-0049-7
Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009).
doi: 10.1093/nar/gkn923
Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
pubmed: 19131956
Oakley, H. et al. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129–10140 (2006).
pubmed: 17021169
pmcid: 6674618
doi: 10.1523/JNEUROSCI.1202-06.2006
Weksler, B. et al. Blood–brain barrier‐specific properties of a human adult brain endothelial cell line. FASEB J. 19, 1872–1874 (2005).
pubmed: 16141364
doi: 10.1096/fj.04-3458fje
Youden, W. J. Index for rating diagnostic tests. Cancer 3, 32–35 (1950).
pubmed: 15405679
doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3